Crystalline Pyraclostrobin Synthesis via Solvent Parameter Shift

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing crystalline methyl N-[2-[[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]phenyl]-N-methoxycarbamate (pyraclostrobin) require additional crystallization steps and are hindered by side reactions with alcohols and ketones, making them unsuitable for large-scale synthesis.

Innovation Solution

A process involving the reaction of a compound of formula II with an alkylating agent in the presence of a base and a polar solvent selected from alcohols and ketones, with the addition of water, which allows for the direct production of crystalline pyraclostrobin without the need for further solvent crystallization, using preferred solvents like methanol and acetone, and bases such as potassium hydroxide, and optimizing reaction conditions to achieve high yields.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If alcohols are used as polar solvents in the alkylation reaction, then the reaction can proceed, but unwanted side-reactions between DMS and the alcohol occur

Engineering Contradiction:
Improvereaction feasibilityVSAvoidside-reactions
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent changes the solvent parameter from alcohol to ketone, fundamentally altering the chemical environment to eliminate side-reactions while maintaining reaction feasibility. This parameter change transforms the problematic alcohol solvent into a non-interfering ketone solvent.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the previously harmful alcohol solvent into a beneficial ketone solvent by recognizing that ketones undergo self-condensation rather than side-reactions with DMS. This transforms a harmful interaction into a beneficial process that maintains reaction conditions without unwanted by-products.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Ease of manufacture

If ketones are used as polar solvents in the alkylation reaction, then the reaction can proceed, but self-condensation (aldol-reaction) occurs

Engineering Contradiction:
Improvereaction feasibilityVSAvoidself-condensation
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent optimizes the ketone solvent parameters by selecting specific ketones (acetone, methyl-ethyl ketone, butanone) and controlling reaction conditions (temperature, base concentration) to minimize self-condensation while maintaining reaction feasibility.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces a base as an intermediary that facilitates the main alkylation reaction while controlling ketone self-condensation. The base mediates between the ketone solvent and the reaction components, enabling the desired transformation while suppressing unwanted side-reactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If additional crystallization steps are added to produce crystalline material, then crystalline pyraclostrobin can be obtained, but the process complexity and time increase

Engineering Contradiction:
Improvecrystalline material productionVSAvoidprocess steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent merges the reaction and crystallization steps into a single integrated process. The crystalline product precipitates directly from the reaction mixture during the alkylation reaction, eliminating the need for separate crystallization steps and reducing process complexity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The reaction system performs self-crystallization, where the product automatically precipitates in crystalline form during the reaction process. This self-service mechanism eliminates the need for external crystallization intervention, reducing both time and process complexity.

Inventive Principle:
Principle #25Self-service

4Object-generated harmful factors

If polar aprotic solvents are used instead of alcohols and ketones, then side-reactions are minimized, but the production of crystalline material requires additional steps

Engineering Contradiction:
Improveside-reactionsVSAvoidcrystallization steps
Core Design Contradiction:
Object-generated harmful factorsVSDevice complexity

Solution Approach 1:

The patent changes the solvent class from polar aprotic to polar protic (ketones), which paradoxically enables both minimal side-reactions and self-crystallization. This parameter change allows the system to achieve multiple objectives simultaneously that were mutually exclusive with polar aprotic solvents.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively produces crystalline pyraclostrobin at high yields without additional crystallization steps, minimizing side reactions and water content, and is suitable for large-scale synthesis, particularly in solvent-free formulations like suspension concentrates.

Implementation Method 1

reacting a compound of formula II with an alkylating agent in the presence of a base

Methodology Applied
Scientific EffectAlkylation reaction: Chemical Bonding

Implementation Method 2

the addition of water... direct production of crystalline pyraclostrobin without the need for further solvent crystallization

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Data Source

PatentEP3334712B1A novel process for preparing crystalline methyl n-[2-[[[1-(4-chlorophenyl)-1h-pyrazol-3-yl]oxy]methyl]phenyl]-n-methoxycarbamate
Publication Date: 2019.10.09 BASF SE
  • EP3334712B1 patent drawing
  • EP3334712B1 patent drawing
  • EP3334712B1 patent drawing

AI summary

The present invention relates to a process for preparing crystalline methyl N-[2-[[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]phenyl]-N-methoxycarbamate (I), comprising a) reacting a compound of formula (II) with an alkylating agent in the presence of a base in the presence of a polar solvent selected from alcohols and ketons; b) the addition of water.